维普中文期刊产品整合服务
29篇 您的检索式:作者名="Bochtler"
    题名 作者 年代 出处 被引量
1Met- hods and models for integrated modeling of products and processes显示文摘EVERSHEIM W BOCHTLER W LAUFENBERG L 1994Production Engineering1994,2,1:1
2B7-H1 on hepatocytes facilitates priming of specific CD8 ^+ T ceils but limits the specific recall of primed responses 显示文摘Wahl C Bochtler P Chen L 2008Gastroenterology2008,135,3:1
3Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability显示文摘Bochtler T Hegenbart U Cremer FW 2008Blood2008,111,9:1
4A methodology for an integrated design and process planning based on a concurrent engineering reference model显示文摘EVERSHEIM W ROZENFEID H BOCHTLER W 1995Annals of the CIRP1995,44,1:1
5Molecular machines for protein degradation显示文摘Groll M Bochtler M Brandstetter 0,,:1
6Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability显示文摘Bochtler T Hegenbart U Cremer FW 2008Blood2008,111,:1
7The proteasome显示文摘Bochtler M Ditzel L Groll M 1999Annu Rev Biophys Biomol Struct1999,28,:1
8DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function显示文摘Loffler H Bochtler T Fritz B 2007Cell Cycle2007,6,20:1
9A methodology for an integrated design and process planning based on a concurrent engineering reference model显示文摘EVESHEIN W ROZENFELD H BOCHTLER W 1999Annals of the CIRP1999,44,1:1
10Current diagnostic and therapy of light chain amyloidosis 显示文摘Schonland SO Bochtler T Hegenbart U 2009Pathology2009,30,3:1
11Current diagnostic and therapy of light chain amyloidosis 显示文摘Schonland SO Bochtler T Kristen AV 2009Pathologe2009,30,3:1
12The proteasome 显示文摘Bochtler M Ditzel L Groll M 1999Annu Rev Biophys Biomol Struct1999,28,:1
13The proteasome显示文摘BOCHTLER M DITZEL L GROLL M 1999Annu Rev Biophys Biomol Struct1999,28,29:1
14Evaluation of the serum- free light chain test in untreated patients with AL amyloidosis显示文摘Bochtler T Hegenbart U Heiss C 2008Haematologica2008,93,3:1
15Immunohistochemistry in the classification of systemic forms of amyloidosis:a systematic investigation of 117 patients显示文摘Sch(o)nland SO Hegenbart U Bochtler T 2012{H}Blood2012,,2:1
16The proteasome显示文摘BOCHTLER M DITZEL L GROLL M 1999Annu Rev Biophys Biomol Struct1999,28,:1
17Current diagnostic and therapy of light chain amyloidosis显示文摘Schonland SO Bochtler T Kristen AV 2009Pathologe2009,30,:1
18Molecular machines for protein degradation 显示文摘Groll M Bochtler M Brandstetter H Clausen T Huber R 2005Chembiochem2005,6,2:1
19DNA damage-induced accumulation of centrosomal Chkl contributes to its checkpoint function 显示文摘Loftier H Bochtler T Fritz B 2007Cell Cycle2007,6,20:1
20Gain of chromosome 1q21is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexame-thasone显示文摘Bochtler T Hegenbart U Kunz C 2014Amyloid2014,21,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费